These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10762636)

  • 1. Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents.
    Villa R; Folini M; Perego P; Supino R; Setti E; Daidone MG; Zunino F; Zaffaroni N
    Int J Oncol; 2000 May; 16(5):995-1002. PubMed ID: 10762636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
    Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
    Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.
    Asai A; Kiyozuka Y; Yoshida R; Fujii T; Hioki K; Tsubura A
    Anticancer Res; 1998; 18(3A):1465-72. PubMed ID: 9673357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity and telomere lengths in various cell lines: changes of telomerase activity can be another method for chemosensitivity evaluation.
    Park KH; Rha SY; Kim CH; Kim TS; Yoo NC; Kim JH; Roh JK; Noh SH; Min JS; Lee KS; Kim BS; Chung HC
    Int J Oncol; 1998 Sep; 13(3):489-95. PubMed ID: 9683783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity in ovarian tumors.
    Murakami J; Nagai N; Ohama K; Tahara H; Ide T
    Cancer; 1997 Sep; 80(6):1085-92. PubMed ID: 9305709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents.
    Smith V; Dai F; Spitz M; Peters GJ; Fiebig HH; Hussain A; Burger AM
    J Chemother; 2009 Nov; 21(5):542-9. PubMed ID: 19933046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel telomere elongation in an adriamycin-resistant stomach cancer cell line with decreased telomerase activity.
    Kim JH; Lee GE; Kim JC; Lee JH; Chung IK
    Mol Cells; 2002 Apr; 13(2):228-36. PubMed ID: 12018844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term cultivation of colorectal carcinoma cells with anti-cancer drugs induces drug resistance and telomere elongation: an in vitro study.
    Kuranaga N; Shinomiya N; Mochizuki H
    BMC Cancer; 2001; 1():10. PubMed ID: 11518543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line.
    Furuta M; Nozawa K; Takemura M; Izuta S; Murate T; Tsuchiya M; Yoshida K; Taka N; Nimura Y; Yoshida S
    Int J Cancer; 2003 May; 104(6):709-15. PubMed ID: 12640677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
    Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD
    Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
    Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
    Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of telomerase activity and telomere length to chemosensitivity.
    Kiyozuka Y
    Methods Mol Med; 2005; 111():97-108. PubMed ID: 15911975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative in situ evaluation of telomeres in fluorescence in situ hybridization-processed sections of cutaneous melanocytic lesions and correlation with telomerase activity.
    Miracco C; Margherita De Santi M; Schürfeld K; Santopietro R; Lalinga AV; Fimiani M; Biagioli M; Brogi M; De Felice C; Luzi P; Andreassi L
    Br J Dermatol; 2002 Mar; 146(3):399-408. PubMed ID: 11952539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in human ovarian carcinoma.
    Counter CM; Hirte HW; Bacchetti S; Harley CB
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):2900-4. PubMed ID: 8159676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells.
    Biroccio A; Gabellini C; Amodei S; Benassi B; Del Bufalo D; Elli R; Antonelli A; D'Incalci M; Zupi G
    Mol Pharmacol; 2003 Mar; 63(3):632-8. PubMed ID: 12606771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor.
    Incles CM; Schultes CM; Kelland LR; Neidle S
    Mol Pharmacol; 2003 Nov; 64(5):1101-8. PubMed ID: 14573759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous regression of cutaneous melanoma in sinclair swine is associated with defective telomerase activity and extensive telomere erosion.
    Pathak S; Multani AS; McConkey DJ; Imam AS; Amoss MS
    Int J Oncol; 2000 Dec; 17(6):1219-24. PubMed ID: 11078808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased telomerase activity is not a reliable indicator of chemosensitivity in testicular cancer cell lines.
    Cressey TR; Tilby MJ; Newell DR
    Eur J Cancer; 2002 Mar; 38(4):586-93. PubMed ID: 11872354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.